Karipharma SRL
The score of Karipharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +1 % Total assets -15 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Karipharma's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 108,353 € | ||||
| Equity | 632,727 € | ||||
| Cash | 41,083 € | ||||
| EBITDA | 128,384 € | ||||
| Total assets | 827,778 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 17 Jun 2026
- Year ended 31 Dec 2024filed on 23 Jun 2025
- Year ended 31 Dec 2023filed on 24 Jun 2024
- Year ended 31 Dec 2022filed on 29 Jun 2023
- Year ended 31 Dec 2021filed on 16 Jun 2022
Karipharma's financial analysis
- Solvency76.4%sector median: 54.9%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Karipharma
Karipharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0479.817.428
- VAT number
- BE0479817428
- Peppol
- Registered · 0208:0479817428 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 21 Mar 2003
- Registered office
- 1742 Ternat
- Latest accounts
- 2025 · filed on 17 Jun 2026
- Activity
- Other business support service activities n.e.c. (NACE 82990)
Karipharma (SRL) has been based in Ternat since 2003, active in: other business support service activities n.e.c.. For 2025, it reports a net profit of 108,353 € and equity of 632,727 €; its revenue is not published. Its solvency stands at 76.4%, above the median of its sector (54.9%).
Companies similar to Karipharma
Companies in the same business, of comparable size and area, outside its group.
- Patrick Carmans Other business support service activities n.e.c. Hélécine · balance sheet 829,722 €
- Ti-Nebo Other business support service activities n.e.c. Zonhoven · balance sheet 822,719 €
- X-SON Other business support service activities n.e.c. Wijnegem · balance sheet 812,904 €
- Frelyne Other business support service activities n.e.c. Ghent · balance sheet 810,552 €
- DS Pharma Services Other business support service activities n.e.c. Oud-Turnhout · balance sheet 814,618 €
- E.L.H Proxy Other business support service activities n.e.c. Forest · balance sheet 852,663 €
- Annalice Other business support service activities n.e.c. Jurbise · balance sheet 802,796 €
- IMO Vastgoed Groep Other business support service activities n.e.c. Keerbergen · balance sheet 802,444 €
Frequently asked questions about Karipharma
What is the revenue of Karipharma?
Karipharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Karipharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0479817428 for Karipharma, if the company is VAT-registered. Its company number (CBE) is 0479.817.428.
Where is the registered office of Karipharma?
According to the CBE register, the registered office of Karipharma is in 1742 Ternat.
What is the equity of Karipharma?
At the close of the 2025 financial year, the equity of Karipharma amounts to 632,727 €, a solvency of 76.4% of total assets.
Who manages Karipharma?
The register lists 2 active mandates at Karipharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Karipharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →